Cross-Sectional Analysis of Adverse Dermatologic Events Reported to the FDA After Use of GLP-1 Agonists.
Bianca E ItuarteMitchell A TaylorSierra I ThomasDivya SharmaRobin HighAshley WysongErin X WeiPublished in: Journal of drugs in dermatology : JDD (2024)
Keyphrases